Find out how treatments like chemotherapy, radiation, or immunotherapy can help fight your B-cell lymphoma and put the disease in remission.

B-cell lymphoma and its treatments can weaken your immune system and increase your risk for infection. Learn ways to avoid getting sick while you're in cancer treatment.

Lymphoblastic lymphoma Lymphoblastic lymphoma largely affects T-cell lymphocytes, a type of cell that works with B-cells to produce antibodies.

The FDA has loosened safety restrictions for six CAR T-cell immunotherapies, used in treating a number of blood cancers.

It is designed to treat lymphoblastic leukaemia and diffuse large B-cell lymphoma. India’s Kauvery Hospital has announced the launch of its CAR-T cell therapy service for certain blood cancers that do ...

Antibody–Drug Conjugates for the Treatment of B-cell Non–Hodgkin's Lymphoma and Leukemia Yu-Waye Chu; Andrew Polson Disclosures Future Oncol. 2013;9 (3):355-368.

Therapy-related B-lymphoblastic leukemia (B-ALL) following treatment for multiple myeloma is a rare occurrence. Despite its rarity and the lack of recognition by the World Health Organization as a ...

Acute lymphoblastic leukemia/lymphoma (ALL), also called acute lymphocytic leukemia and acute lymphoid leukemia, is a type of blood cancer that starts with a change to a single cell in the bone marrow ...

The Food and Drug Administration granted a priority review to Blincyto for the treatment of early-stage CD19-positive B-cell acute lymphoblastic leukemia.

Conclusions In summary, we present an interesting case of B-lymphoblastic leukemia with unusual surface light chain expression in a patient who has previously undergone myeloma treatment.

Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents? Leuk Lymphoma. 2020;61:7-17.